Trulieve Cannabis Corp.
TRLVHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Jun 18, 2026
Scan Results
Daily timeframeTrulieve Cannabis Corp. operates as a cannabis retailer in the United States. With a market capitalization of $1.82B, it sits in small-cap territory. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.
Market Cap
$1.82B
Beta
1.86
P/E (TTM)
—
P/E (Fwd)
39.38
EPS (TTM)
$-0.40
EPS (Fwd)
$0.24
ROE
-6.9%
ROA
3.3%
Cash
$352.9M
Total Debt
$629.8M
Free CF
$201.4M
52W Change
174.2%
Annual Financials
Cash vs Debt
The company holds $352.9M in cash, though total debt stands at $629.8M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $201.4M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -6.9% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.3% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $1.22B (2022) to $1.18B (2025).
Trulieve Cannabis Corp.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Trulieve Cannabis Corp.'s trajectory.